#Seroprevalence

Kelly Doran MD MHS

KellyMDoran

Really important new study on seroprevalence of SARS-CoV-2 among people living in precarious housing situations (including shelters) in Ile de France. A thread. https://epicentre.msf.org/sites/default/files/2020-10/High_seroprevalence_of_

Maciek Boni

maciekboni

Hi #epitwitter short summary here on @athutran's results on optimal vaccine allocation using real-time seroprevalence estimates, for MA and RI (abt 25% to 30% seroprev on Jan 1). Results exactly

Yehuda Veod

VeodLekra

[Thread]Certain Hasidic communities have stopped social distancing two months ago, and there seem to be few mask-wearers.Yet, there has been no detectable rise in infections. It's a shame that this

Anup Malani

anup_malani

I'm excited to see our Karnataka sero-prevalence study out in @JAMA_current today. This is part of a longer chain of surveys we've done to track and understand COVID in India

COVID Impact

CovidSerology

Manaus has now surpassed the very tragic 26/04 burial record of 167 with 198 burials in the past 24H (13/01) for a total of 1486 burials in January with 50%

Tara Moriarty

MoriartyLab

Any excess mortality experts out there?I'm looking the cumulative excess mortality tracker table on @OurWorldInDatahttps://ourworldindata.org/grapher/excess-mortality-cumulative-deaths?tab=table&stackMode=absolute&time=earliest.

A Marm Kilpatrick

DiseaseEcology

Is herd immunity now high enough to contribute to reduced transmission of #COVID19?Thread from @trvrb is provoking substantial discussion as it should. I'd like to add a few details that

Sumanth Raman

sumanthraman

India's seroprevalance survey shows only 21% seropositivity to #Covid19 ,hardly enough to have created herd immunity. Yet cases are falling consistently. There are 3 broad areas we need to work

Michael Mina

michaelmina_lab

Important: on the resurgence of SARS-CoV-2 in a place where herd immunity was already attained.The authors lay out 4 reasons:1) didn’t actually attain herd immunity2) waning immunity3) new strains evading

Isobel Routledge

IsobelRoutledge

Really excited to say our paper describing our citywide serosurveillance of the initial SARS-CoV-2 outbreak San Francisco (#SCALEIT) is now up as a pre-print!https://www.researchsquare.com/article/rs-180966/v1 1/10 "Gold standard"

Diego Bassani, PhD 🏠😷

DGBassani

“Keeping schools open & finding safe strategies to do it should be prioritized. But that means refraining from the narrative that children don’t get infected and schools don’t spread the

Jeremy Konyndyk

JeremyKonyndyk

Very interesting paper distilling the (still quite patchy) evidence base on schools and COVID transmission. Nothing radically new, but further affirmation that while the picture is murky, the risks are

A Marm Kilpatrick

DiseaseEcology

How not to do a #COVID19 seroprevalence studyNew paper out today from CDC that is so problematic I want to cry.(great material for @callin_bull)Quick thread.https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834 Backgroun

Apoorva Mandavilli

apoorva_nyc

How are you all holding up? Shall I tweet out a second set of papers? Or are you too stressed to pay attention? 1. This Lancet Global Health Paper is

Björn Meyer

_b_meyer

Seeing that B1.1.7 now acquired the E484K mutation in the UK, could we, at least for now, stop the narrative that this double mutation occurs by high immune pressure, please?because

Anup Malani

anup_malani

Just getting around to reading this paper on, inter alia, t-cell response in seronegative persons. H/T @andreasantlab. Key quote: Robust T cell immunity in convalescent individuals with asymptomatic or mild

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.